An "olivomycin A" derivative from a sponge-associated sp. strain SP 85.

Mohsen Gozari, Nima Bahador, Mohammad Seddiq Mortazavi, Ebrahim Eftekhar, Amir Reza Jassbi
Author Information
  1. Mohsen Gozari: 1Department of Microbiology, College of Science, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran. ORCID
  2. Nima Bahador: 1Department of Microbiology, College of Science, Agriculture and Modern Technology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
  3. Mohammad Seddiq Mortazavi: 2Persian Gulf and Oman Sea Ecological Research Center, Iranian Fisheries Science Research Institute (IFSRI), Agricultural Research, Education and Extension Organization (AREEO), Bandar 'Abbas, Iran. ORCID
  4. Ebrahim Eftekhar: 3Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar 'Abbas, Iran. ORCID
  5. Amir Reza Jassbi: 4Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ORCID

Abstract

We isolated an actinobacterium, sp. strain SP 85 from the marine sponge Polyphasic identification of the microorganism showed that the strain SP 85 had high 16S rRNA gene similarity (99%) with strain NBRC 12805, while some physiological and biochemical differences were observed. A cytotoxic compound, was isolated from the active culture extract of the strain SP 85 by bioassay-guided purification over silica gel column chromatography, preparative TLC, and HPLC. The structure elucidation based on the spectroscopic analysis, including UV, ESI-MS, and C NMR data revealed that compound is an analog of anti-tumor drug, "olivomycin A". The compound showed high cytotoxic activity against three human cancer cell lines, including SW480, HepG2, and MCF7 with IC values of 16, 93, and 78 nM, respectively. exhibited significantly (2-10 times) higher cytotoxicity against the tumor cell lines in comparison with HUVECs as the normal cell line, which also induced apoptosis in the tested cancerous cell line. This is the first report on the production of an "olivomycin A" derivative by a sponge-associated , showing the great potential of sponge-associated actinobacteria in producing cytotoxic natural products.

Keywords

References

  1. Oncotarget. 2017 Sep 16;8(46):81662-81678 [PMID: 29113422]
  2. J Med Chem. 2012 Jun 28;55(12):5813-25 [PMID: 22578073]
  3. Appl Microbiol Biotechnol. 2016 Mar;100(6):2869-82 [PMID: 26590587]
  4. J Basic Microbiol. 2007 Dec;47(6):496-505 [PMID: 18072250]
  5. Trends Cancer. 2017 Jan;3(1):2-6 [PMID: 28603778]
  6. J Pharm Pharmacol. 2013 Feb;65(2):157-70 [PMID: 23278683]
  7. Nat Prod Rep. 2014 Mar;31(3):381-99 [PMID: 24496105]
  8. Microbiol Res. 2012 Dec 20;167(10):590-5 [PMID: 22789867]
  9. Cell Chem Biol. 2017 Oct 19;24(10):1194-1195 [PMID: 29053949]
  10. Sci Rep. 2017 May 22;7(1):1660 [PMID: 28533520]
  11. Methods Mol Biol. 2012;864:27-41 [PMID: 22367892]
  12. Appl Environ Microbiol. 2017 Feb 1;83(4): [PMID: 27986719]
  13. Mol Biol Evol. 1987 Jul;4(4):406-25 [PMID: 3447015]
  14. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):E1130-9 [PMID: 24616526]
  15. Appl Environ Microbiol. 1997 Aug;63(8):3233-41 [PMID: 9251210]
  16. Mar Biotechnol (NY). 2009 May-Jun;11(3):384-96 [PMID: 18953608]
  17. J Biol Chem. 2003 Sep 26;278(39):37832-9 [PMID: 12853461]
  18. J Antibiot (Tokyo). 1988 Jan;41(1):53-67 [PMID: 3346193]
  19. Oncotarget. 2015 Mar 10;6(7):4569-84 [PMID: 25625193]
  20. J Nat Prod. 2008 Feb;71(2):199-207 [PMID: 18197601]
  21. Nat Prod Rep. 2009 May;26(5):628-60 [PMID: 19387499]
  22. Int Microbiol. 2019 Dec;22(4):521-530 [PMID: 31144066]
  23. J Antibiot (Tokyo). 1988 Jan;41(1):45-52 [PMID: 3346192]
  24. Microb Cell Fact. 2016 Feb 22;15:44 [PMID: 26905289]
  25. Bioorg Med Chem. 2011 Sep 1;19(17):5183-9 [PMID: 21807523]
  26. Appl Microbiol Biotechnol. 2006 Nov;73(1):1-14 [PMID: 17013601]
  27. Nat Rev Microbiol. 2012 Sep;10(9):641-54 [PMID: 22842661]
  28. J Comput Biol. 2000 Feb-Apr;7(1-2):203-14 [PMID: 10890397]
  29. Nat Rev Genet. 2005 Feb;6(2):119-27 [PMID: 15716908]
  30. Evolution. 1985 Jul;39(4):783-791 [PMID: 28561359]
  31. Mol Biol Evol. 2016 Jul;33(7):1870-4 [PMID: 27004904]
  32. Nat Prod Rep. 2018 Jan 25;35(1):8-53 [PMID: 29335692]
  33. Genome Announc. 2015 Oct 01;3(5):null [PMID: 26430030]
  34. Int J Mol Sci. 2012;13(5):5917-32 [PMID: 22754340]

Word Cloud

Created with Highcharts 10.0.0strainSP85cellcytotoxiccompound"olivomycinA"sponge-associatedisolatedspshowedhighanalysisincludinglineslinederivativeactinobacteriummarinespongePolyphasicidentificationmicroorganism16SrRNAgenesimilarity99%NBRC12805physiologicalbiochemicaldifferencesobservedactivecultureextractbioassay-guidedpurificationsilicagelcolumnchromatographypreparativeTLCHPLCstructureelucidationbasedspectroscopicUVESI-MSCNMRdatarevealedanaloganti-tumordrugactivitythreehumancancerSW480HepG2MCF7ICvalues169378 nMrespectivelyexhibitedsignificantly2-10timeshighercytotoxicitytumorcomparisonHUVECsnormalalsoinducedapoptosistestedcancerousfirstreportproductionshowinggreatpotentialactinobacteriaproducingnaturalproductsAnti-tumorantibioticsDysideaavaraOlivomycinPhylogeneticSponge-associatedStreptomyces

Similar Articles

Cited By